Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentin V Vlassov

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Biomaterials|October 17, 2016
'Dual' peptidyl-oligonucleotide conjugates: Role of conformational flexibility in catalytic cleavage of RNAYaroslav Staroseletz, Aled Williams, Kepa K Burusco, et al.
FEBS Letters|June 28, 2011
Silencing activity of 2'-O-methyl modified anti-MDR1 siRNAs with mismatches in the central part of the duplexesNatalya S Petrova, Mariya I Meschaninova, Alya G Venyaminova, et al.
FEBS Letters|February 25, 2014
42- and 63-bp anti-MDR1-siRNAs bearing 2'-OMe modifications in nuclease-sensitive sites induce specific and potent gene silencingOlga V Gvozdeva, Iiya S Dovydenko, Alya G Venyaminova, et al.
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|August 9, 2012
Inactivation of the tick-borne encephalitis virus by RNA-cleaving compoundsElena P Goncharova, Ludmila S Koroleva, Vladimir N Silnikov, et al.
International Journal of Molecular Sciences|December 11, 2025
Biological Performance and Molecular Mechanisms of Mesyl MicroRNA-Targeted Oligonucleotides in Colorectal Cancer CellsSvetlana K Miroshnichenko, Olga A Patutina, Andrey V Markov, et al.
Oligonucleotides|October 30, 2010
2'-O-methyl-modified anti-MDR1 fork-siRNA duplexes exhibiting high nuclease resistance and prolonged silencing activityNatalya S Petrova Kruglova, Mariya I Meschaninova, Alya G Venyaminova, et al.
BMC Cancer|May 18, 2010
The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapyOlga A Patutina, Nadezda L Mironova, Nelly A Popova, et al.
Molecules (Basel, Switzerland)|April 25, 2020
Trimeric Small Interfering RNAs and Their Cholesterol-Containing Conjugates Exhibit Improved Accumulation in Tumors, but Dramatically Reduced Silencing ActivityIvan V Chernikov, Daniil V Gladkikh, Ulyana A Karelina, et al.
Annals of the New York Academy of Sciences|November 17, 2006
Circulating DNA and DNase activity in human bloodSvetlana N Tamkovich, Anna V Cherepanova, Elena V Kolesnikova, et al.
Journal of Nucleic Acids|October 1, 2011
Site-selective artificial ribonucleases: oligonucleotide conjugates containing multiple imidazole residues in the catalytic domainNatalia G Beloglazova, Martin M Fabani, Nikolai N Polushin, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Biomaterials|October 17, 2016
'Dual' peptidyl-oligonucleotide conjugates: Role of conformational flexibility in catalytic cleavage of RNAYaroslav Staroseletz, Aled Williams, Kepa K Burusco, et al.
FEBS Letters|June 28, 2011
Silencing activity of 2'-O-methyl modified anti-MDR1 siRNAs with mismatches in the central part of the duplexesNatalya S Petrova, Mariya I Meschaninova, Alya G Venyaminova, et al.
FEBS Letters|February 25, 2014
42- and 63-bp anti-MDR1-siRNAs bearing 2'-OMe modifications in nuclease-sensitive sites induce specific and potent gene silencingOlga V Gvozdeva, Iiya S Dovydenko, Alya G Venyaminova, et al.
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|August 9, 2012
Inactivation of the tick-borne encephalitis virus by RNA-cleaving compoundsElena P Goncharova, Ludmila S Koroleva, Vladimir N Silnikov, et al.
International Journal of Molecular Sciences|December 11, 2025
Biological Performance and Molecular Mechanisms of Mesyl MicroRNA-Targeted Oligonucleotides in Colorectal Cancer CellsSvetlana K Miroshnichenko, Olga A Patutina, Andrey V Markov, et al.
Oligonucleotides|October 30, 2010
2'-O-methyl-modified anti-MDR1 fork-siRNA duplexes exhibiting high nuclease resistance and prolonged silencing activityNatalya S Petrova Kruglova, Mariya I Meschaninova, Alya G Venyaminova, et al.
BMC Cancer|May 18, 2010
The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapyOlga A Patutina, Nadezda L Mironova, Nelly A Popova, et al.
Molecules (Basel, Switzerland)|April 25, 2020
Trimeric Small Interfering RNAs and Their Cholesterol-Containing Conjugates Exhibit Improved Accumulation in Tumors, but Dramatically Reduced Silencing ActivityIvan V Chernikov, Daniil V Gladkikh, Ulyana A Karelina, et al.
Annals of the New York Academy of Sciences|November 17, 2006
Circulating DNA and DNase activity in human bloodSvetlana N Tamkovich, Anna V Cherepanova, Elena V Kolesnikova, et al.
Journal of Nucleic Acids|October 1, 2011
Site-selective artificial ribonucleases: oligonucleotide conjugates containing multiple imidazole residues in the catalytic domainNatalia G Beloglazova, Martin M Fabani, Nikolai N Polushin, et al.
Pageof 11